Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:00 PM
Ignite Modification Date: 2025-12-25 @ 12:19 PM
NCT ID: NCT02282761
Description: None
Frequency Threshold: 5
Time Frame: From signing ICF until end of study procedures (~49 days), including 28 days of double-blind treatment
Study: NCT02282761
Study Brief: A Trial to Assess the Antipsychotic Efficacy of ITI-007
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Lumateperone 28 mg (ITI-007 40 mg Tosylate) Lumateperone 28 mg (ITI-007 40 mg Tosylate) administered orally as formulated capsules once daily for 28 days ITI-007 0 None 1 150 55 150 View
Lumateperone 42 mg (ITI-007 60 mg Tosylate) Lumateperone 42 mg (ITI-007 60 mg Tosylate) administered orally as formulated capsules once daily for 28 days ITI-007 0 None 0 150 70 150 View
Placebo Placebo administered orally as formulated capsules once daily for 28 days Placebo 1 None 1 149 41 149 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Convulsion SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Asthma SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (17.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Sedation SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Dry Mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Fatigue SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View